Moderna Inc

MRNA•United States

Healthcare United States Biological ProductsOptions Available

Need professional-grade analysis? Visit stockanalysis.com

$51.34

-0.08%

End of day

Market Cap

$16.02B

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	—	—	13.23	7.26	1.18	—	6.22
Calmar	—	—	24.05	13.18	1.42	—	11.00
Sharpe	—	—	6.32	3.96	0.74	—	3.21
Omega	—	—	1.70	1.50	1.18	—	1.42
Martin	—	—	52.35	29.87	2.45	—	24.06
Ulcer	—	—	10.41	10.00	20.61	—	14.53

Also Listed On

0QF.XETRA

XETRA (Frankfurt) · EUR

$18.01B

Moderna Inc (MRNA) Price Performance

Moderna Inc (MRNA) trades on United States in USD. The company is classified in the Healthcare sector under the Biological Products industry. The stock currently trades at $51.34, down 0.08% from the previous close.

Over the past year, MRNA has traded between a low of $22.36 and a high of $57.80. The stock has gained 63.1% over this period. It is currently 11.2% below its 52-week high.

Moderna Inc has a market capitalization of $16.02B.

Company Info

Sector: Healthcare
Industry: Biological Products
Exchange: United States
Currency: USD
Country: United States

Financial Metrics

Revenue (TTM): $6.85B
EBITDA: $-3,255,000,064
Profit Margin: -139.61%
EPS (TTM): -12.34
Book Value: 23.86

Technical Indicators

52 Week High: $59.55
52 Week Low: $22.28
50 Day MA: $35.09
200 Day MA: $29.00
Beta: 1.34

Valuation

Trailing P/E: N/A
Forward P/E: N/A
Price/Sales: 7.18
Price/Book: 1.72
Enterprise Value: $12.25B